There is only a short window of opportunity to seek medical help before rabies becomes almost invariably fatal, but people wait an average of 10 days before seeking medical advice following exposure to potentially rabid animals overseas, according to new research being presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) […]Continue Reading ...
Approximately 1.5 million Americans use cocaine in a given year, according to the National Institute on Drug Abuse. Many are repeat users. Unfortunately, there are currently no FDA-approved medicinal treatments for cocaine addiction. Behavioral therapy is the only treatment option for patients with cocaine addiction. Unfortunately, many treated patients remain susceptible to relapse when re-exposed […]Continue Reading ...
Relationship impairment (difficulty managing expectations and requirements within an intimate relationship) plays a role in explaining the association between symptom severity and those seeking treatment among post-9/11 military veterans. However, the role it plays is different for men and women. In men, relationship impairment appears to interfere with seeking treatment for post-traumatic stress disorder (PTSD) […]Continue Reading ...
The Trump administration Friday finalized a regulation intended to push Planned Parenthood out of the Title X federal family planning program, keeping a campaign promise to anti-abortion groups. The program provides contraceptives, screening and treatment for sexually transmitted diseases and other primary health services to 4 million patients each year, many of them low-income or […]Continue Reading ...
- New gene therapy cures babies with fatal ‘Bubble Boy’ disease
- No female mice? Scientists may still approve NIH grant
- What needs to be said about mental health in medicine
- Hickenlooper Expanded Medicaid, Created State-Run Marketplace To Insure Nearly All Coloradans
- Cancer cells grown in tumor-mimicking environment can help predict the effect of experimental drugs
- Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat for the Treatment of NAFLD/NASH
- Adhesive gel bonds to eye surface, could repair injuries without surgery
- The future of genomics: A podcast featuring Stanford geneticists
- As Syphilis Invades Rural America, A Fraying Health Safety Net Is Failing To Stop It
- APOE gene impacts sleep depending on gender and severity of Alzheimer’s
- PCORI’s newly approved awards focus on cancer pain and opioid use disorders
- New tool provides a standard way to measure effects of caring for survivors of TBI
- Smartphone use risks eye examination misdiagnosis
- How drug-resistant bugs grow in CF patients’ lungs
- Gordana Vunjak-Novakovic Elected to American Academy of Arts & Sciences
- Podcast: KHN’s ‘What The Health?’ You Have Questions, We Have Answers
- Diabetic drug shows potential to be repurposed as heart disease treatment for non-diabetic patients
- New estimation method assesses natural variations in sex ratio at birth
- UTA scientist receives $1.17 million grant for cancer research
- Coagulation factor VIIa prevents bleeds in hemophilia animal models